Dual JAK and ROCK inhibition with CPL'116 in patients with rheumatoid arthritis with inadequate response to methotrexate: a randomised, double-blind, placebo-controlled, phase 2 trial

https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(25)00060-8/abstract Dual JAK and ROCK inhibition and comorbidities in rheumatoid arthritis https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(25)00111-0/abstract